Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Cl B (HUGE)

Fsd Pharma Inc Cl B (HUGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,318
  • Shares Outstanding, K 39,359
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,900 K
  • 60-Month Beta 0.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.52
Trade HUGE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings $-0.04 on 03/28/24
  • Latest Earnings Date 05/10/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 378.70% ( +11.38%)
  • Historical Volatility 51.70%
  • IV Percentile 98%
  • IV Rank 86.40%
  • IV High 437.68% on 04/09/24
  • IV Low 3.94% on 12/04/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 5,533
  • Open Int (30-Day) 4,756

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4184 +13.81%
on 04/17/24
0.7300 -34.77%
on 03/20/24
-0.2538 (-34.77%)
since 03/19/24
3-Month
0.4184 +13.81%
on 04/17/24
1.0900 -56.31%
on 02/21/24
-0.3998 (-45.64%)
since 01/19/24
52-Week
0.4184 +13.81%
on 04/17/24
1.6799 -71.65%
on 09/18/23
-1.0438 (-68.67%)
since 04/19/23

Most Recent Stories

More News
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

/PRNewswire/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against...

HUGE : 0.4759 (+2.26%)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION

/CNW/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against his...

HUGE.CN : 0.6400 (unch)
HUGE : 0.4759 (+2.26%)
FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END

CELH : 69.60 (-0.53%)
RXDX : 199.92 (+0.09%)
HUGE : 0.4759 (+2.26%)
OMER : 3.14 (-2.18%)
MRK : 125.22 (-0.01%)
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry

/PRNewswire/ -- Alcohol consumption and drug abuse have become public health concerns worldwide. Governments are working on ways to detect any symptoms of...

CELH : 69.60 (-0.53%)
HUGE : 0.4759 (+2.26%)
OMER : 3.14 (-2.18%)
MRK : 125.22 (-0.01%)
RXDX : 199.92 (+0.09%)
FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)
FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)
FSD Pharma Announces Filing of Year-End 2022 Results

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)
FSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.4759 (+2.26%)
HUGE.CN : 0.6400 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

See More

Key Turning Points

3rd Resistance Point 0.5510
2nd Resistance Point 0.5243
1st Resistance Point 0.4948
Last Price 0.4759
1st Support Level 0.4386
2nd Support Level 0.4119
3rd Support Level 0.3824

See More

52-Week High 1.6799
Fibonacci 61.8% 1.1980
Fibonacci 50% 1.0491
Fibonacci 38.2% 0.9003
Last Price 0.4759
52-Week Low 0.4184

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar